Sarah McGarry

Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states

Andrew Sulaiman, Sarah McGarry, Li Li et al. · Molecular Oncology · 2018 · 72 citations · Full text

A triple-drug nanotherapy to target breast cancer cells, cancer stem cells, and tumor vasculature

Sara El‐Sahli, Khang Hua, Andrew Sulaiman et al. · Cell Death and Disease · 2021 · 48 citations · Full text

Co-inhibition of mTORC1, HDAC and ESR1α retards the growth of triple-negative breast cancer and suppresses cancer stem cells

Andrew Sulaiman, Sarah McGarry, Ka Mien Lam et al. · Cell Death and Disease · 2018 · 45 citations · Full text

Both bulk and cancer stem cell subpopulations in triple‐negative breast cancer are susceptible to Wnt, <scp>HDAC</scp>, and <scp>ER</scp>α coinhibition

Andrew Sulaiman, Brandon Sulaiman, Lara Khouri et al. · FEBS Letters · 2016 · 30 citations · Full text

Co-targeting Bulk Tumor and CSCs in Clinically Translatable TNBC Patient-Derived Xenografts via Combination Nanotherapy

Andrew Sulaiman, Sarah McGarry, Sara El‐Sahli et al. · Molecular Cancer Therapeutics · 2019 · 29 citations